| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/DKW354 |
| P698 | PubMed publication ID | 27650184 |
| P50 | author | Athanassios Tsakris | Q90648868 |
| P2093 | author name string | Joseph Meletiadis | |
| George L Daikos | |||
| Johan W Mouton | |||
| Loukia Zerva | |||
| Sophia Vourli | |||
| Marilena Tsala | |||
| P2860 | cites work | Tigecycline: first of a new class of antimicrobial agents | Q28253736 |
| High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria | Q33754471 | ||
| Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using In Vivo Microdialysis | Q34309522 | ||
| Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes | Q34320945 | ||
| Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies | Q35532816 | ||
| Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia | Q35666608 | ||
| Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model | Q35666627 | ||
| Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections | Q35840772 | ||
| The pharmacokinetic and pharmacodynamic profile of tigecycline | Q36218318 | ||
| Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections | Q36422712 | ||
| In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae isolates | Q37247732 | ||
| Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.). | Q37364437 | ||
| Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline | Q37864882 | ||
| Quantitative aspects of septicemia | Q37946740 | ||
| Tigecycline: an update | Q38077344 | ||
| Confronting carbapenemase-producing Klebsiella pneumoniae | Q38135903 | ||
| Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs | Q39953659 | ||
| Pharmacokinetic-pharmacodynamic modelling of meropenem against VIM-producing Klebsiella pneumoniae isolates: clinical implications | Q40177874 | ||
| Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy | Q40704822 | ||
| Tetracyclines: antibiotic action, uptake, and resistance mechanisms | Q41004630 | ||
| Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013). | Q41113428 | ||
| In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a KPC Carbapenemase | Q41858894 | ||
| Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials | Q42643577 | ||
| Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens | Q46062198 | ||
| Optimal tigecycline dosage regimen is urgently needed: results from a pharmacokinetic/pharmacodynamic analysis of tigecycline by Monte Carlo simulation | Q46108407 | ||
| Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia | Q50802868 | ||
| Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli. | Q54346626 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Klebsiella pneumoniae | Q132592 |
| pharmacodynamics | Q725307 | ||
| P304 | page(s) | 172-180 | |
| P577 | publication date | 2016-09-19 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Impact of bacterial load on pharmacodynamics and susceptibility breakpoints for tigecycline and Klebsiella pneumoniae | |
| P478 | volume | 72 |
| Q90073378 | Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats | cites work | P2860 |
Search more.